NCODA Announces Inaugural Clinical Advances Summit for October 2027
The National Community Oncology Drug Specialists Association (NCODA) has announced its first-ever Clinical Advances Summit (NCAS), scheduled for October 2027. The new summit aims to bring together international oncology experts to discuss clinical innovations, research trends, and the evolving landscape of cancer care. Florida Cancer Specialists & Research Institute (FCS) leaders have expressed strong support for the initiative. Dr. Lucio N. Gordan, President and Managing Physician of FCS and a member of NCODA's board, has been appointed co-chair of the NCAS to guide its scientific direction. Several FCS executives were also recognized as part of NCODA's 2026 Fellows class. The expansion of NCODA's programming reflects a growing industry focus on multidisciplinary collaboration and the translation of emerging clinical evidence into community oncology practice.
Topics: Cancer Care Clinical Innovation Oncology Professional Leadership